In contrast, a study from Norway reported 10 deaths in 68 BRCA1 mutation carriers at a median follow-up of 4.2 years for an estimated five-year breast cancer specific survival of only 75% and 10-year survival of 69% [51]. Here, BRCA1 is linked to breast carcinoma.